Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma
Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma.
Pharmacogenomics.
2018,
20(2),
113-127,
ISSN: 1462-2416,
PMID: 30539680,